Recent Advances in Metal-Based Drug Delivery Systems for Cancer Therapy
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: 31 August 2026 | Viewed by 1568
Editors
2. Instituto de Investigación en Tecnologías para la Sostenibilidad (ITPS), Móstoles, Madrid
3. Grupo de Investigación COMET-NANO, Móstoles, Madrid
Interests: metallodrugs; platinum; ruthenium; bioinorganic chemistry; coordination chemistry; chemotherapy; photochemistry; drug design
Special Issue Information
Dear Colleagues,
We are pleased to invite you to contribute to our Special Issue “Recent Advances in Metal-Based Drug Delivery Systems for Cancer Therapy”. Metal-based compounds have long played a pivotal role in oncology, with platinum-based drugs such as cisplatin forming the cornerstone of many chemotherapeutic regimens. However, challenges related to toxicity, resistance, and lack of selectivity have spurred extensive research into novel metal complexes and innovative delivery strategies. This Special Issue aims to showcase the latest developments in the design, synthesis, and application of metal-based agents for targeted and controlled drug delivery in cancer treatment.
Special attention will be given to systems involving prodrugs activated by internal stimuli (such as pH or enzymatic activity) or external triggers (including light or ultrasound), offering precise spatiotemporal control over drug release.
We particularly welcome original research and reviews from interdisciplinary fields such as medicinal chemistry, nanomedicine, materials science, pharmacology, and molecular biology that contribute to the advancement of metal-based drug delivery systems for cancer therapy.
Dr. Maria Jesus Moran Plata
Dr. Marta Martínez-Alonso
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- metal-based drug delivery systems
- cancer therapy
- stimuli-responsive prodrugs
- nanomedicine
- coordination complexes
- targeted chemotherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
